` EZZ (EZZ Life Science Holdings Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

EZZ
vs
S&P/ASX 300

Over the past 12 months, EZZ has significantly outperformed S&P/ASX 300, delivering a return of 47% compared to the S&P/ASX 300's 10% growth.

Stocks Performance
EZZ vs S&P/ASX 300

Loading
EZZ
S&P/ASX 300
Add Stock
www.alphaspread.com

Performance Gap
EZZ vs S&P/ASX 300

Loading
EZZ
S&P/ASX 300
Difference
www.alphaspread.com

Performance By Year
EZZ vs S&P/ASX 300

Loading
EZZ
S&P/ASX 300
Add Stock

Competitors Performance
EZZ Life Science Holdings Ltd vs Peers

S&P/ASX 300
EZZ
0KHE
TMO
DHR
207940
Add Stock

EZZ Life Science Holdings Ltd
Glance View

Market Cap
110.4m AUD
Industry
Life Sciences Tools & Services

EZZ Life Science Holdings Ltd. engages in wholesale distributor of skin care products under the EAORON brand to pharmacies, supermarkets and specialist retailers. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-03-03. The firm is wholesale distributor of EAORON skin care products for the Australian and New Zealand markets. The company develops, manufactures and distributes genetic technology enabled consumer health products under its own brand, EZZ. The EAORON brand comprises of five product lines, including Hyaluronic Series, Facial Mask Series, Crystal White Series, Specific Care Series and Anti-Sugar Series. The EZZ products cover market segments, including vitamin and dietary supplements, sports nutrition, wright management and wellbeing, herbal/ traditional and pediatric consumer health products.

EZZ Intrinsic Value
4.3 AUD
Undervaluation 46%
Intrinsic Value
Price
E
Back to Top